One goal is to investigate whether specific treatments are effective in relieving symptoms. In addition to treatment studies, the research staff are involved in numerous studies aimed at understanding the phenomenology and neurobiology of OCD, spectrum disorders, Alzheimer s disease and other disorders. Interdisciplinary collaborative approaches are emphasized. MH 45133-01, Phenelzine, fluoxetine, placebo in OCD, A controlled trial. Other private funds include the Judah Fund, Beard Fund, Agnew Fund, and Moran Fund.
Pharmaceutical industry supports double-blind controlled studies.
The Center was also funded as part of the DSM-IV Field trials. Massachusetts General Hospital Center for Psychiatric Neuroscience at Massachusetts General Hospital-East, Building 149, 9th Floor, 13th Street, Charlestown, MA 02129. Michael A. Jenike, MD, Massachusetts General Hospital Center for Psychiatric Neuroscience at Massachusetts General Hospital-East, Building 149, 9th Floor, 13th Street, Charlestown, MA 02129. Currently there are 4 post-doctoral fellows. Buttolph L. Standardized assessment of personality disorders in obsessive-compulsive disorder.